1.McLeod, DS & Cooper, DS (2012) The incidence and prevalence of thyroid autoimmunity. Endocrine 42, 252–265.
2.Okayasu, I, Hara, Y, Nakamura, K et al. (1994) Racial and age-related differences in incidence and severity of focal autoimmune thyroiditis. Am J Clin Pathol 101, 698–702.
3.Hashimoto, H (1912) Zur Kenntnis der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Archiv für Klinische Chirurgie (in German) 97, 219–248.
4.Effraimidis, G & Wiersinga, WM (2014) Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol 170, R241–R252.
6.Nacamulli, D, Petricca, D & Mian, C (2013) Selenium and autoimmune thyroiditis. J Endocrinol Invest 36, 8–14.
7.Marcocci, C, Kahaly, GJ, Krassas, GE et al. (2011) Selenium and the course of mild Graves’ orbitopathy. N Engl J Med 364, 1920–1931.
8.Brent, GA (2008) Clinical practice. Graves’ disease. N Engl J Med 358, 2594–2605.
9.Hu, S & Rayman, MP (2017) Multiple nutritional factors and the risk of Hashimoto's thyroiditis. Thyroid 27, 597–610.
10.Häggström, M (2014) Synthesis of the thyroid hormones in the thyroid follicle, Medical gallery of Mikael Häggström 2014. Wiki Journal of Medicine 1.
11.Laurberg, P, Cerqueira, C, Ovesen, L et al. (2010) Iodine intake as a determinant of thyroid disorders in populations. Best Practice Res Clinical Endocrinol Metab 24, 13–27.
12.Bülow Pedersen, ILP (2009) Antibodies to thyroid peroxidase and thyroglobulin in iodine deficiencies. In Comprehensive Handbook of Iodine: Nutritional, Biochemical and Pathological Aspects, pp. 575–585 [Preedy, VR, Burrow, GN, Watson, RR, editors]: Burlington, MA: Elsevier.
13.Pedersen, IB, Knudsen, N, Jorgensen, T et al. (2003) Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin Endocrinol (Oxf) 58, 36–42.
14.Teng, W, Shan, Z, Teng, X et al. (2006) Effect of iodine intake on thyroid diseases in China. N Engl J Med 354, 2783–2793.
15.Teng, X, Shan, Z, Chen, Y et al. (2011) More than adequate iodine intake may increase subclinical hypothyroidism and autoimmune thyroiditis: a cross-sectional study based on two Chinese communities with different iodine intake levels. Eur J Endocrinol 164, 943–950.
16.Peng, NC, Shi, LX, Zhang, Q et al. (2013) An epidemiological survey of the prevalence of thyroid diseases in mild iodine deficiency city after salt iodization. Zhonghua Nei Ke Za Zhi 52, 16–20.
17.Zhang, JY, Li, SM, Leng, JL et al. (2013) Changes of the spectrum on thyroid disease after the 10-year implementation of universal salt iodization in Guangxi Zhuang Autonomous Region. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 34, 970–974.
18.Pedersen, IB, Knudsen, N, Carle, A et al. (2011) A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. Clin Endocrinol (Oxf) 75, 120–126.
19.Bjergved, L, Jorgensen, T, Perrild, H et al. (2012) Predictors of change in serum TSH after iodine fortification: an 11-year follow-up to the DanThyr study. J Clin Endocrinol Metab 97, 4022–4029.
20.Cerqueira, C, Knudsen, N, Ovesen, L et al. (2011) Doubling in the use of thyroid hormone replacement therapy in Denmark: association to iodization of salt? Eur J Epidemiol 26, 629–635.
21.Camargo, RY, Tomimori, EK, Neves, SC et al. (2008) Thyroid and the environment: exposure to excessive nutritional iodine increases the prevalence of thyroid disorders in Sao Paulo, Brazil. Eur J Endocrinol 159, 293–299.
22.Zaletel, K, Gaberscek, S & Pirnat, E (2011) Ten-year follow-up of thyroid epidemiology in Slovenia after increase in salt iodization. Croat Med J 52, 615–621.
23.Fernando, RF, Chandrasinghe, PC & Pathmeswaran, AA (2012) The prevalence of autoimmune thyroiditis after universal salt iodisation in Sri Lanka. Ceylon Med J 57, 116–119.
24.Aghini Lombardi, F, Fiore, E, Tonacchera, M et al. (2013) The effect of voluntary iodine prophylaxis in a small rural community: the Pescopagano survey 15 years later. J Clin Endocrinol Metab 98, 1031–1039.
25.Zimmermann, MB & Boelaert, K (2015) Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol 3, 286–295.
26.Burek, CL & Talor, MV (2009) Environmental triggers of autoimmune thyroiditis. J Autoimmun 33, 183–189.
27.Sharma, R, Traore, K, Trush, MA et al. (2008) Intracellular adhesion molecule-1 up-regulation on thyrocytes by iodine of non-obese diabetic.H2(h4) mice is reactive oxygen species-dependent. Clin Exp Immunol 152, 13–20.
28.Duntas, LH (2015) The role of iodine and selenium in autoimmune thyroiditis. Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 47, 721–726.
29.Luo, Y, Kawashima, A, Ishido, Y et al. (2014) Iodine excess as an environmental risk factor for autoimmune thyroid disease. Int J Mol Sci 15, 12895–12912.
31.Institute of Medicine (2001) Panel on Micronutrients: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academies Press (US).
32.WHO/UNICEF/ICCIDD (2007) Assessment of Iodine Deficiency Disorders and Monitoring their Elimination: A Guide for Programme Managers, 3rd ed. Geneva: World Health Organization.
33.Rasmussen, LB, Carle, A, Jorgensen, T et al. (2008) Iodine intake before and after mandatory iodization in Denmark: results from the Danish Investigation of Iodine Intake and Thyroid Diseases (DanThyr) study. Br J Nutr 100, 166–173.
37.Yeh, T, Hung, N & Lin, T (2014) Analysis of iodine content in seaweed by GC-ECD and estimation of iodine intake. J Food Drug Anal 22, 189–196.
38.Dunn, JT & Dunn, AD (2001) Update on intrathyroidal iodine metabolism. Thyroid 11, 407–414.
39.Hess, SY, Zimmermann, MB, Arnold, M et al. (2002) Iron deficiency anemia reduces thyroid peroxidase activity in rats. J Nutr 132, 1951–1955.
40.Fayadat, L, Niccoli-Sire, P, Lanet, J et al. (1999) Role of heme in intracellular trafficking of thyroperoxidase and involvement of H2O2 generated at the apical surface of thyroid cells in autocatalytic covalent heme binding. J Biol Chem 274, 10533–10538.
41.Sategna-Guidetti, C, Bruno, M, Mazza, E et al. (1998) Autoimmune thyroid diseases and coeliac disease. Eur J Gastroenterol Hepatol 10, 927–931.
42.Fisher, AH, Lomasky, SJ, Fisher, MJ et al. (2008) Celiac disease and the endocrinologist: a diagnostic opportunity. Endocr Pract 14, 381–388.
43.Pinto-Sanchez, MI, Bercik, P, Verdu, EF et al. (2015) Extraintestinal manifestations of celiac disease. Dig Dis 33, 147–154.
44.Centanni, M, Marignani, M, Gargano, L et al. (1999) Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intern Med 159, 1726–1730.
45.Checchi, S, Montanaro, A, Ciuoli, C et al. (2010) Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditis. Thyroid : Official J Am Thyroid Assoc 20, 1385–1389.
46.Lahner, E, Centanni, M, Agnello, G et al. (2008) Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am J Med 121, 136–141.
47.Tozzoli, R, Kodermaz, G, Perosa, AR et al. (2010) Autoantibodies to parietal cells as predictors of atrophic body gastritis: a 5-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev 10, 80–83.
48.Erdal, M, Sahin, M, Hasimi, A et al. (2008) Trace element levels in Hashimoto thyroiditis patients with subclinical hypothyroidism. Biol Trace Elem Res 123, 1–7.
49.Nekrasova, TA, Strongin, LG & Ledentsova, OV (2013) Hematological disturbances in subclinical hypothyroidism and their dynamics during substitution therapy. Klin Med (Mosk) 91, 29–33.
50.Szczepanek-Parulska, E, Hernik, A & Ruchala, M (2017) Anemia in thyroid diseases. Polish Archives Internal Med 127, 352–360.
51.Beard, J, Tobin, B & Green, W (1989) Evidence for thyroid hormone deficiency in iron-deficient anemic rats. J Nutr 119, 772–778.
52.Beard, JL, Brigham, DE, Kelley, SK et al. (1998) Plasma thyroid hormone kinetics are altered in iron-deficient rats. J Nutr 128, 1401–1408.
53.Beard, J, Finch, CA & Green, WL (1982) Interactions of iron deficiency, anemia, and thyroid hormone levels in response of rats to cold exposure. Life Sci 30, 691–697.
54.Beard, JL, Borel, MJ & Derr, J (1990) Impaired thermoregulation and thyroid function in iron-deficiency anemia. Am J Clin Nutr 52, 813–819.
55.Zimmermann, MB, Burgi, H & Hurrell, RF (2007) Iron deficiency predicts poor maternal thyroid status during pregnancy. J Clin Endocrinol Metab 92, 3436–3440.
56.Yu, X, Shan, Z, Li, C et al. (2015) Iron deficiency, an independent risk factor for isolated hypothyroxinemia in pregnant and nonpregnant women of childbearing age in China. J Clin Endocrinol Metab 100, 1594–1601.
57.Wiersinga, WM, Duntas, L, Fadeyev, V et al. (2012) 2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J 1, 55–71.
58.Soppi, E (2015) Iron deficiency is the main cause of symptom persistence in patients treated for hypothyroidism. In 15th International Thyroid Congress, Thyroid 25, A–74.
59.Donati, RM, Fletcher, JW, Warnecke, MA et al. (1973) Erythropoiesis in hypothyroidism. Proc Soc Exp Biol Med 144, 78–82.
60.Ravanbod, M, Asadipooya, K, Kalantarhormozi, M et al. (2013) Treatment of iron-deficiency anemia in patients with subclinical hypothyroidism. Am J Med 126, 420–424.
61.Cinemre, H, Bilir, C, Gokosmanoglu, F et al. (2009) Hematologic effects of levothyroxine in iron-deficient subclinical hypothyroid patients: a randomized, double-blind, controlled study. J Clin Endocrinol Metab 94, 151–156.
62.Ajmera, AV, Shastri, GS, Gajera, MJ et al. (2012) Suboptimal response to ferrous sulfate in iron-deficient patients taking omeprazole. Am J Ther 19, 185–189.
63.Martinez-Torres, C, Cubeddu, L, Dillmann, E et al. (1984) Effect of exposure to low temperature on normal and iron-deficient subjects. Am J Physiol 246, R380–R383.
64.EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2015) Scientific opinion on dietary refeerence values for iron. EFSA J 13, 4254. https://doi.org/4210.2903/j.efsa.2015.4254 (accessed May 2018).
65.Hurrell, R & Egli, I (2010) Iron bioavailability and dietary reference values. Am J Clin Nutr 91, 1461s-1467s.
66.Kohrle, J (2013) Selenium and the thyroid. Curr Opin Endocrinol Diabetes Obes 20, 441–448.
67.Schmutzler, C, Mentrup, B, Schomburg, L et al. (2007) Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol Chem 388, 1053–1059.
68.Darras, VM & Van Herck, SL (2012) Iodothyronine deiodinase structure and function: from ascidians to humans. J Endocrinol 215, 189–206.
69.Kohrle, J, Jakob, F, Contempre, B et al. (2005) Selenium, the thyroid, and the endocrine system. Endocr Rev 26, 944–984.
70.Schomburg, L (2011) Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nat Rev Endocrinol 8, 160–171.
71.Schomburg, L & Kohrle, J (2008) On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Mol Nutr Food Res 52, 1235–1246.
72.Curran, JE, Jowett, JB, Elliott, KS et al. (2005) Genetic variation in selenoprotein S influences inflammatory response. Nat Genet 37, 1234–1241.
73.Santos, LR, Duraes, C, Mendes, A et al. (2014) A polymorphism in the promoter region of the selenoprotein S gene (SEPS1) contributes to Hashimoto's thyroiditis susceptibility. J Clin Endocrinol Metab 99, E719–E723.
74.Derumeaux, H, Valeix, P, Castetbon, K et al. (2003) Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. Eur J Endocrinol 148, 309–315.
75.Wu, Q, Rayman, MP, Lv, H et al. (2015) Low population selenium status is associated with increased prevalence of thyroid disease. J Clin Endocrinol Metab 100, 4037–4047.
76.Rasmussen, LB, Schomburg, L, Kohrle, J et al. (2011) Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. Eur J Endocrinol 164, 585–590.
77.Rayman, MP & Duntas, L (2018) Selenium deficiency and thyroid disease. In The Thyroid and Its Diseases [Luster, M and Duntas, L and Wartofsky, L, editors]: New York: Springer.
78.Glattre, E, Thomassen, Y, Thoresen, SO et al. (1989) Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol 18, 45–49.
79.Lin, JC, Kuo, WR, Chiang, FY et al. (2009) Glutathione peroxidase 3 gene polymorphisms and risk of differentiated thyroid cancer. Surgery 145, 508–513.
80.Bulow Pedersen, I, Knudsen, N, Carle, A et al. (2013) Serum selenium is low in newly diagnosed Graves’ disease: a population-based study. Clin Endocrinol (Oxf) 79, 584–590.
81.WHO/UNICEF/ICCIDD (2007) Assessment of Iodine Deficiency Disorders and Monitoring their Elimination, 3rd ed. Geneva: WHO.
82.Teng, X, Shi, X, Shan, Z et al. (2008) Safe range of iodine intake levels: a comparative study of thyroid diseases in three women population cohorts with slightly different iodine intake levels. Biol Trace Elem Res 121, 23–30.
83.Liu, Y, Liu, S, Mao, J et al. (2018) Serum trace elements profile in graves’ disease patients with or without orbitopathy in Northeast China. BioMed Res Int 2018, 3029379.
84.Khong, JJ, Goldstein, RF, Sanders, KM et al. (2014) Serum selenium status in graves’ disease with and without orbitopathy: a case-control study. Clin Endocrinol (Oxf) 80, 905–910.
85.Hesse-Bahr, K, Dreher, I & Kohrle, J (2000) The influence of the cytokines Il-1beta and INFgamma on the expression of selenoproteins in the human hepatocarcinoma cell line HepG2. Biofactors 11, 83–85.
86.Nichol, C, Herdman, J, Sattar, N et al. (1998) Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response? Clin Chem 44, 1764–1766.
87.Watt, T, Cramon, P, Bjorner, JB et al. (2013) Selenium supplementation for patients with Graves’ hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial. Trials 14, 119.
88.Wichman, JWK, Bonnema, SJ & Hegedus, L (2016) Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: a systematic review and meta-analysis. Thyroid 26, 1081–1092.
89.van Zuuren, EJ, Albusta, AY, Fedorowicz, Z et al. (2013) Selenium supplementation for Hashimoto's thyroiditis. Cochrane Database Syst Rev CD010223.
90.Fan, Y, Xu, S, Zhang, H et al. (2014) Selenium supplementation for autoimmune thyroiditis: a systematic review and meta-analysis. Int J Endocrinol 2014, 904573.
91.Duntas, LH & Benvenga, S (2015) Selenium: an element for life. Endocrine 48, 756–775.
92.Pirola, I, Gandossi, E, Agosti, B et al. (2016) Selenium supplementation could restore euthyroidism in subclinical hypothyroid patients with autoimmune thyroiditis. Endokrynol Pol 67, 567–571.
93.de Farias, CR, Cardoso, BR, de Oliveira, GM et al. (2015) A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypes. J Endocrinol Invest 38, 1065–1074.
94.Winther, KH, Watt, T, Bjorner, JB et al. (2014) The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial. Trials 15, 115.
95.Mehran, L, Amouzegar, A, Delshad, H et al. (2013) Trimester-specific reference ranges for thyroid hormones in Iranian pregnant women. J Thyroid Res 2013, 651517.
96.Stagnaro-Green, A (2012) Approach to the patient with postpartum thyroiditis. J Clin Endocrinol Metab 97, 334–342.
97.Negro, R, Greco, G, Mangieri, T et al. (2007) The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 92, 1263–1268.
98.Mao, J, Pop, VJ, Bath, SC et al. (2016) Effect of low-dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-to-moderate iodine deficiency. Eur J Nutr 55, 55–61.
99.Johnson, CC, Fordyce, FM & Rayman, MP (2010) Symposium on ‘Geographical and geological influences on nutrition’: factors controlling the distribution of selenium in the environment and their impact on health and nutrition. Proc Nutr Soc 69, 119–132.
100.Rayman, MP (2012) Selenium and human health. Lancet (London, England) 379, 1256–1268.
101.Rayman, MP (2005) Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 64, 527–542.
102.Rayman, MP (2008) Food-chain selenium and human health: emphasis on intake. Br J Nutr 100, 254–268.
103.Rayman, MP, Thompson, AJ, Bekaert, B et al. (2008) Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom. Am J Clin Nutr 87, 370–378.
104.Krysiak, R & Okopien, B (2011) The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis. J Clin Endocrinol Metab 96, 2206–2215.
105.Duntas, LH, Mantzou, E & Koutras, DA (2003) Effects of a 6 month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol 148, 389–393.
106.Lippman, SM, Klein, EA, Goodman, PJ et al. (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301, 39–51.
107.Duffield-Lillico, AJ, Slate, EH, Reid, ME et al. (2003) Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst 95, 1477–1481.
108.Stranges, S, Marshall, JR, Natarajan, R et al. (2007) Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 147, 217–223.
109.Duffield-Lillico, AJ, Reid, ME, Turnbull, BW et al. (2002) Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 11, 630–639.
110.Kristal, AR, Darke, AK, Morris, JS et al. (2014) Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst 106, djt456.
111.Rayman, MP, Winther, KH, Pastor-Barriuso, R et al. (2018) Effect of long-term selenium supplementation on mortality: results from a multiple-dose, randomised controlled trial. Free Radic Biol Med [Epublication ahead of print version].